STRONGBRIDGE BIOPHARMA
Strongbridge Biopharma’s primary focus has been to build its franchise around rare endocrine disorders, which includes product candidates for the treatment of endogenous Cushing’s syndrome and acromegaly, two rare diseases with a high unmet need for innovative treatment options. Given the well-identified and concentrated prescriber base addressing its target markets, the Company intends to use a small, focused sales force to market its products, if approved, in the United States, European Union and other key global markets. The Company intends to identify and in-license or acquire products or product candidates that would be complementary to its existing rare endocrine franchise or that would form the basis for new rare disease franchises.
STRONGBRIDGE BIOPHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1996-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.strongbridgebio.com
Total Employee:
101+
Status:
Active
Contact:
+111610254920
Email Addresses:
[email protected]
Total Funding:
196.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Cloudflare Hosting COVID-19 Cloudflare DNS Microsoft Vimeo
Similar Organizations
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-06-01 | Aspire Pharmaceuticals | Aspire Pharmaceuticals acquired by Strongbridge Biopharma | N/A |
Investors List
Armentum Partners
Armentum Partners investment in Debt Financing - Strongbridge Biopharma
CRG
CRG investment in Post-IPO Equity - Strongbridge Biopharma
CRG
CRG investment in Post-IPO Debt - Strongbridge Biopharma
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Strongbridge Biopharma
Horizon Technology Finance
Horizon Technology Finance investment in Post-IPO Debt - Strongbridge Biopharma
Broadfin Capital
Broadfin Capital investment in Venture Round - Strongbridge Biopharma
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Strongbridge Biopharma
HealthCap
HealthCap investment in Venture Round - Strongbridge Biopharma
RA Capital Management
RA Capital Management investment in Venture Round - Strongbridge Biopharma
Third Swedish National Pension Fund
Third Swedish National Pension Fund investment in Venture Round - Strongbridge Biopharma
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-07 | Strongbridge Biopharma plc Announces Appointment of John H. Johnson to Chief Executive Officer |
Official Site Inspections
http://www.strongbridgebio.com
- Host name: 172.67.214.16
- IP address: 172.67.214.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
